Report: Merck in ‘advanced talks' to acquire Seattle-area biotech giant Seagen for around $40BGeekWire • 07/07/22
Merck Is Now in Advanced Talks to Buy Cancer Biotech Seagen for $40 Billion: ReportBarrons • 07/07/22
Only 8 Of The 30 Dow Jones Stocks Were Positive In The First Half Of 2022: Chevron Leads, But Who Else Was Up?Benzinga • 07/01/22